Depo-Medrone with Lidocaine 40/10 mg/1 ml Injection (1 x 1ml vial) May Pharm with a more stable structure

with a more stable structure

Allows the user to perform various injection techniques according to treatment site

there is minimal waste and the risk of cross-contamination is reduced

HP Vitaran S polynucleotides effectively stimulate cell metabolism

Depo-Medrone with Lidocaine 40/10 mg/1 ml Injection (1 x 1ml vial) May Pharm with a more stable structureDepo Medrone contains corticosteroid, methylprednisolone acetate and lidocaine. May be injected directly into joints and soft tissues in the treatment of rheumatoid arthritis, osteoarthritis, bursitis and other inflammatory conditions. It has greater anti inflammatory potency than prednisolone. Depo Medrone may be used by any of the following routes: intramuscular, intra articular, periarticular, intrabursal, intralesional or into the tendon sheath.